Search results
Results From The WOW.Com Content Network
At the healthcare conference, Moderna lowered expected 2025 revenue to the range of $1.5 billion to $2.5 billion -- down from a September forecast of $2.5 billion to $3.5 billion. And Moderna said ...
Moderna said it expects 2025 revenue to range between $1.5 billion and $2.5 billion after hitting as much as $3.1 billion last year. Analysts expect, on average, $2.92 billion in revenue for 2025 ...
The Motley Fool recommends Marvell Technology, Moderna, and Southwest Airlines and recommends the following options: long January 2026 $395 calls on Microsoft, short February 2025 $27 calls on ...
Moderna's massive revenue adjustment, and how it highlights the company's need to diversify revenue streams. Shake Shack 's new plans to open up 1,500 company-owned locations.
As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural for investors to wonder about where the biotech will go in the near ...
Moderna expects to have $6 billion as cash on hand by 2024 end, which according to Jefferies analyst Michael Yee was at the lower end of its prior view of $6 billion to $7 billion.
Now, management expects 2025 revenue to fall into a range between $1.5 billion and $2.5 billion. The lower end of the range represents a roughly 50% revenue reduction.
We are preparing to launch multiple products through 2025, including our RSV vaccine. We expect to return to sales growth in 2025 and, through disciplined investment, to break even in 2026," said ...